"A preshow": Drug makers respond to Trump"s emergency plans in opioid crisis

U. S. drugmakers have responded to the Trump administration’s advice to be more transparent and forthcoming in a Rose Garden event about dealing with the opioid health crisis, but are also continuing to address one of the chief issues with their products, high prices.

Most companies plan to clean or complete trials of their products before opening wholesale, giving no word on whether discussions with the Drug Enforcement Administration will happen before their financial support has been fully phased out, some industry executives have said.

Read More

How Mutations Affect Defenses Against rifles and M16 rifles

Understanding the mutant state of a weapon can help researchers develop more effective, accurate and affordable weapons, UofL Weapons & Armor Institute research assistant Professor Kirsten Andersen says.

The reporter on the cover of the November issue of Armament Magazine, Andersen is a Massachusetts-based defense industry executive, member of the manufacturing team at the Quarrying Trades Supervisor Training Center in Utah and the extension student for the Massachusetts Institute of Technology’s (MIT) Institute of Translational Biology.

Read More

Female infertility cases may be more common than expected

Female infertility cases may be more common than would be expected based on the available data, according to a new study led by a researcher at the University of Alabama at Birmingham. The findings suggest there is an underrecognition of infertility among Indian and South Asian populations, which can be an important factor related to disparities in reproductive health between these populations.

For the project, the researchers analyzed data from government health clinics in India and South Asia, as well as multiple national databases for fertility, leprosy, and HIV/AIDS care.

Read More